Gustafson

  • The decreased level of serum GSH following CCl4 administration was not considerably elevated in the CI+CCl4 group. Furthermore, the level of malondialdehyde in the serum of CI+CCl4 rats was decreased, compared to the CCl4 group. The main compositions of the essential oil from the C. intybus distillate were the antioxidants of Pulegone (8.10%),…[Read more]

  • Gustafson posted an update 12 months ago

    7; 95 % CI 4.3-5.1]; Opioid+/ NAS- [aRR 3.7; 95 %CI 3.1-4.5]) and a year after birth (Opioid+/ NAS+ [aRR 3.7; 95 %CI 3.4-4.0]; Opioid+/ NAS- [aRR 2.8; 95 %CI 2.3-3.4]). Infants with maternal opioid exposure and/or NAS were more likely than Opioid-/NAS- infants to have ≥2 sick visits and any ED visits in the year after birth.

    Infants with N…[Read more]

  • Gustafson posted an update 12 months ago

    Therefore, the suitability of Ca-based nanoparticles-doped optical fibers for distributed sensing over longer distances, from 5 m to more than 200 m, becomes possible. This study opens a new path for future works in the field of distributed sensing, since these findings may be applied to other nanoparticles-doped optical fibers, allowing the…[Read more]

  • Gustafson posted an update 1 year ago

    Simulation-based methods such as approximate Bayesian computation (ABC) are well-adapted to the analysis of complex scenarios of populations and species genetic history. In this context, supervised machine learning (SML) methods provide attractive statistical solutions to conduct efficient inferences about scenario choice and parameter estimation.…[Read more]

  • Gustafson posted an update 1 year ago

    6%) and 101 (2.6%) clients were HIV positive. Individuals tested at the stand-alone centers were at a 1.91-fold higher risk of being HIV positive compared with those tested at the mobile VCT unit. Individuals who were 20-24 or >24 years old, sex workers, or sexually transmitted infection positive were more likely to be HIV positive. Our results…[Read more]

  • Gustafson became a registered member 1 year ago

Skip to toolbar